Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Association between smoking status, and free, total and percent free prostate specific antigen.

Li J, Thompson T, Joseph DA, Master VA.

J Urol. 2012 Apr;187(4):1228-33. doi: 10.1016/j.juro.2011.11.086.

2.

Effect of cigarette smoking on biochemical outcome after permanent prostate brachytherapy.

Merrick GS, Butler WM, Wallner KE, Galbreath RW, Lief JH, Adamovich E.

Int J Radiat Oncol Biol Phys. 2004 Mar 15;58(4):1056-62.

PMID:
15001245
3.

Association between glomerular filtration rate, free, total, and percent free prostate-specific antigen.

Joseph DA, Thompson T, Saraiya M, Werny DM.

Urology. 2010 Nov;76(5):1042-6. doi: 10.1016/j.urology.2009.05.100.

PMID:
19781743
4.

Total, free, and percent free prostate-specific antigen levels among U.S. men, 2001-04.

Lacher DA, Thompson TD, Hughes JP, Saraiya M.

Adv Data. 2006 Dec 4;(379):1-12.

PMID:
17348177
5.

Total and percent free prostate-specific antigen levels among U.S. men, 2001-2002.

Saraiya M, Kottiri BJ, Leadbetter S, Blackman D, Thompson T, McKenna MT, Stallings FL.

Cancer Epidemiol Biomarkers Prev. 2005 Sep;14(9):2178-82.

6.

Health risk behaviors and prostate specific antigen awareness among men in California.

Ahmed FS, Borrell LN, Spencer BA.

J Urol. 2008 Aug;180(2):658-62; discussion 662. doi: 10.1016/j.juro.2008.04.007.

7.

The effect of obesity and lower serum prostate-specific antigen levels on prostate-cancer screening results in American men.

Culp S, Porter M.

BJU Int. 2009 Nov;104(10):1457-61. doi: 10.1111/j.1464-410X.2009.08646.x.

8.

Percent free PSA as an additional measure in a prostate cancer screen.

Miele ME.

Clin Lab Sci. 2001 Spring;14(2):102-7.

PMID:
15625982
9.
10.

Shiftwork and prostate-specific antigen in the National Health and Nutrition Examination Survey.

Flynn-Evans EE, Mucci L, Stevens RG, Lockley SW.

J Natl Cancer Inst. 2013 Sep 4;105(17):1292-7. doi: 10.1093/jnci/djt169.

11.

Percent free prostate specific antigen and cancer detection in black and white men with total prostate specific antigen 2.5 to 9.9 ng./ml.

Fowler JE Jr, Sanders J, Bigler SA, Rigdon J, Kilambi NK, Land SA.

J Urol. 2000 May;163(5):1467-70.

PMID:
10751859
12.

Diagnostic value of percent free prostate-specific antigen: retrospective analysis of a population-based screening study with emphasis on men with PSA levels less than 3.0 ng/mL.

Törnblom M, Norming U, Adolfsson J, Becker C, Abrahamsson PA, Lilja H, Gustafsson O.

Urology. 1999 May;53(5):945-50.

PMID:
10223488
13.

Total, free, and complexed prostate-specific antigen levels among US men, 2007-2010.

Lacher DA, Hughes JP.

Clin Chim Acta. 2015 Aug 25;448:220-7. doi: 10.1016/j.cca.2015.06.009.

PMID:
26093340
14.
15.

Circulating total testosterone and PSA concentrations in a nationally representative sample of men without a diagnosis of prostate cancer.

Peskoe SB, Joshu CE, Rohrmann S, McGlynn KA, Nyante SJ, Bradwin G, Dobs AS, Kanarek N, Nelson WG, Platz EA.

Prostate. 2015 Aug 1;75(11):1167-76. doi: 10.1002/pros.22998.

16.

Association of obesity with prostate specific antigen and prostate specific antigen velocity in healthy young men.

Chang IH, Han JH, Ahn SH.

J Urol. 2008 Mar;179(3):886-90; discussion 890-1. doi: 10.1016/j.juro.2007.10.066.

PMID:
18207169
17.
18.

Predictive value of total and percent free prostate specific antigen in high grade prostatic intraepithelial neoplasia lesions: results of the Tyrol Prostate Specific Antigen Screening Project.

Horninger W, Volgger H, Rogatsch H, Strohmeyer D, Steiner H, Hobisch A, Klocker H, Bartsch G.

J Urol. 2001 Apr;165(4):1143-5.

PMID:
11257656
19.

Percent free prostate-specific antigen (PSA) is an accurate predictor of prostate cancer risk in men with serum PSA 2.5 ng/mL and lower.

Walz J, Haese A, Scattoni V, Steuber T, Chun FK, Briganti A, Montorsi F, Graefen M, Huland H, Karakiewicz PI.

Cancer. 2008 Nov 15;113(10):2695-703. doi: 10.1002/cncr.23885.

Items per page

Supplemental Content

Support Center